论文部分内容阅读
一般认为,进行性的恶性肿瘤,多伴有细胞性免疫功能的低下。根据传统,观察恶性肿瘤患者的细胞免疫功能,都用测定延迟型过敏反应的方法。作者采用DNCB作测定过敏反应的试剂,来观察肺癌患者的细胞免疫功能,同时探讨DNCB反应和肺癌患者的临床病期、组织类型、手术可能性及三年生存率的关系。
It is generally believed that progressive malignant tumors are often accompanied by a decrease in cellular immunity. According to tradition, the cellular immune function of patients with malignant tumors is measured by a method for measuring delayed allergic reactions. The authors used DNCB as a reagent for measuring allergic reactions to observe the cellular immune function in patients with lung cancer. At the same time, the relationship between DNCB response and the clinical stage, tissue type, possibility of surgery, and three-year survival rate of lung cancer patients was explored.